DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration . . . The document provides guidance to assist sponsors in the clinical development of nicotine replacement therapy (NRT) drug products, including but not limited to those intended for smoking cessation and related chronic indications
Federal Register :: Smoking Cessation and Related Indications . . . The document provides guidance to assist sponsors in the clinical development of nicotine replacement therapy (NRT) drug products, including but not limited to those intended for smoking cessation and related chronic indications
Nicotine Replacement Therapy - StatPearls - NCBI Bookshelf Implement personalized nicotine replacement therapy plans depending on the patient's smoking habits and preferences and provide clear instructions on proper usage, dosing, and duration
Clinical Guidelines for Prescribing Pharmacotherapy for Smoking . . . All five of the FDA-approved pharmacotherapies for smoking cessation are recommended including bupropion SR, nicotine gum, nicotine inhaler, nicotine nasal spray, and the nicotine patch What factors should a clinician consider when choosing among the five first-line pharmacotherapies?
Coverage for Tobacco Use Cessation Treatments | CDC All Food and Drug Administration (FDA)-approved tobacco cessation medications (including both prescription and over-the-counter medications) for a 90-day treatment regimen when prescribed by a health care provider without prior authorization